Biocidal products must be phased off the NI market Following evaluation under the EU BPR, a decision has been taken not to approve the following active substance/product type combination. This will affect NI: Biocidal products containing this active substance in the relevant product type can no longer be: - supplied in NI after 23 October 2024; or
- used in NI after 23 April 2025
You must manage your stocks of the affected products to ensure they are removed from the NI supply chain by 23 October 2024. New treated articles containing this active substance in the relevant product type cannot enter the supply chain or be imported into NI after 20 April 2024. Treated articles that have entered NI supply chains before this date can continue to be supplied and used. Find out more about treated articles Any affected NI product approvals under the Control of Pesticides Regulations (COPR) will be revoked in line with the above dates. If you are aware of any disproportionate negative impacts that are likely to arise from the non-approval of the active substance/product type combination listed above, please contact us. Biocidal products must be phased off the NI market The active substance/product type combinations listed below are due to expire under the EU BPR on the following dates. This affects NI: - Methyl-benzimidazol-2-ylcarbamate (Carbendazim) (CAS 10605-21-7 EC 234-232-0) in product types 07 and 10
31 January 2025
- Thiamethoxam (CAS 153719-23-4 EC 428-650-4) in product type 18
31 January 2025
- Powdered Corn Cob (CAS n/a EC n/a) in product type 14
31 January 2025
Once the approvals expire, the active substances can no longer be used in biocidal products or treated articles of the relevant product types in Northern Ireland. If you hold an affected EU BPR product authorisation or COPR product approval, we will contact you about cancelling or revoking your authorisation or approval. You will have an opportunity to submit comments or additional information and we will take account of these when finalising our decision. If you are aware of any disproportionate negative impacts that are likely to arise from the expiry of any of the active substance/product type combinations listed above, please contact us. |